| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 983 | 14 | 730 | 84 | 1023 | 203 | 1236 |
| ERLYTX | 94 | 0 | 0 | 4 | 49 | 12 | 73 |
| GI | 194 | 3 | 157 | 12 | 146 | 28 | 170 |
| GU | 440 | 8 | 417 | 33 | 402 | 72 | 438 |
| LEUK | 139 | 4 | 209 | 11 | 134 | 24 | 146 |
| LUNG | 207 | 5 | 261 | 17 | 207 | 30 | 183 |
| LYMPH | 394 | 8 | 417 | 33 | 402 | 65 | 396 |
| MELAN | 291 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 161 | 0 | 0 | 3 | 37 | 15 | 91 |
| MULT | 19 | 2 | 104 | 6 | 73 | 14 | 85 |
| OTHER | 39 | 0 | 0 | 4 | 49 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2968 | 44 | 2295 | 208 | 2534 | 470 | 2860 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 114 | 2 | 104 | 12 | 146 | 26 | 158 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 663 | 11 | 574 | 46 | 560 | 99 | 603 |
| LUNG | 299 | 8 | 417 | 26 | 317 | 64 | 390 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 36 | 2 | 104 | 6 | 73 | 12 | 73 |
| PEOLC | 123 | 6 | 313 | 19 | 231 | 36 | 219 |
| PREV | 221 | 5 | 261 | 15 | 183 | 38 | 231 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 577 | 12 | 626 | 47 | 572 | 97 | 590 |
| Total | 2063 | 47 | 2451 | 175 | 2131 | 381 | 2319 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 983 | 14 | 730 | 84 | 1023 | 203 | 1236 |
| CCD | 114 | 2 | 104 | 12 | 146 | 26 | 158 |
| ERLYTX | 104 | 0 | 0 | 4 | 49 | 13 | 79 |
| GI | 194 | 3 | 157 | 12 | 146 | 28 | 170 |
| GU | 440 | 8 | 417 | 33 | 402 | 72 | 438 |
| LEUK | 802 | 15 | 783 | 57 | 694 | 123 | 749 |
| LUNG | 506 | 13 | 678 | 43 | 524 | 94 | 572 |
| LYMPH | 395 | 8 | 417 | 33 | 402 | 65 | 396 |
| MELAN | 291 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 161 | 0 | 0 | 3 | 37 | 15 | 91 |
| MULT | 19 | 2 | 104 | 6 | 73 | 14 | 85 |
| OTHER | 75 | 2 | 104 | 10 | 122 | 17 | 103 |
| PEOLC | 123 | 6 | 313 | 19 | 231 | 36 | 219 |
| PREV | 224 | 5 | 261 | 15 | 183 | 38 | 231 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 579 | 12 | 626 | 47 | 572 | 97 | 590 |
| Total | 5031 | 91 | 4746 | 383 | 4665 | 851 | 5178 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 605 | 10 | 522 | 52 | 633 | 133 | 810 |
| ERLYTX | 51 | 0 | 0 | 3 | 37 | 7 | 43 |
| GI | 143 | 2 | 104 | 10 | 122 | 21 | 128 |
| GU | 369 | 6 | 313 | 23 | 280 | 52 | 317 |
| LEUK | 85 | 2 | 104 | 7 | 85 | 14 | 85 |
| LUNG | 130 | 1 | 52 | 8 | 97 | 15 | 91 |
| LYMPH | 252 | 6 | 313 | 25 | 304 | 40 | 244 |
| MELAN | 185 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 101 | 0 | 0 | 1 | 12 | 7 | 43 |
| MULT | 7 | 0 | 0 | 2 | 24 | 5 | 30 |
| OTHER | 39 | 0 | 0 | 4 | 49 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1974 | 27 | 1408 | 136 | 1655 | 301 | 1833 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 101 | 2 | 104 | 11 | 134 | 22 | 134 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 304 | 4 | 209 | 26 | 317 | 45 | 274 |
| LUNG | 182 | 4 | 209 | 15 | 183 | 41 | 250 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 36 | 2 | 104 | 6 | 73 | 12 | 73 |
| PEOLC | 87 | 5 | 261 | 15 | 183 | 27 | 164 |
| PREV | 221 | 5 | 261 | 15 | 183 | 38 | 231 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 391 | 10 | 522 | 31 | 377 | 60 | 365 |
| Total | 1352 | 33 | 1722 | 123 | 1499 | 254 | 1546 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 790 | 10 | 522 | 64 | 779 | 160 | 974 |
| CCD | 135 | 3 | 157 | 11 | 134 | 31 | 189 |
| ERLYTX | 61 | 0 | 0 | 3 | 37 | 8 | 49 |
| GI | 149 | 2 | 104 | 10 | 122 | 24 | 146 |
| GU | 389 | 8 | 417 | 26 | 317 | 57 | 347 |
| LEUK | 389 | 6 | 313 | 33 | 402 | 59 | 359 |
| LUNG | 313 | 5 | 261 | 23 | 280 | 56 | 341 |
| LYMPH | 253 | 6 | 313 | 25 | 304 | 40 | 244 |
| MELAN | 185 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 98 | 0 | 0 | 1 | 12 | 7 | 43 |
| MULT | 21 | 0 | 0 | 3 | 37 | 6 | 37 |
| OTHER | 250 | 6 | 313 | 18 | 219 | 46 | 280 |
| PEOLC | 95 | 4 | 209 | 14 | 170 | 27 | 164 |
| PREV | 224 | 5 | 261 | 15 | 183 | 38 | 231 |
| SURV | 19 | 1 | 52 | 4 | 49 | 8 | 49 |
| SXQOL | 393 | 10 | 522 | 31 | 377 | 60 | 365 |
| Total | 3766 | 66 | 3444 | 282 | 3434 | 629 | 3830 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 837 | 12 | 626 | 68 | 828 | 158 | 962 |
| ERLYTX | 90 | 0 | 0 | 4 | 49 | 11 | 67 |
| GI | 109 | 3 | 157 | 7 | 85 | 18 | 110 |
| GU | 249 | 7 | 365 | 22 | 268 | 48 | 292 |
| LEUK | 108 | 3 | 157 | 9 | 110 | 20 | 122 |
| LUNG | 176 | 4 | 209 | 14 | 170 | 26 | 158 |
| LYMPH | 317 | 4 | 209 | 24 | 292 | 53 | 323 |
| MMYEL | 150 | 0 | 0 | 3 | 37 | 14 | 85 |
| MULT | 19 | 2 | 104 | 6 | 73 | 14 | 85 |
| Total | 2055 | 35 | 1827 | 157 | 1912 | 362 | 2204 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1955 | 34 | 1774 | 162 | 1972 | 341 | 2076 |
| AFFIL | 120 | 5 | 261 | 11 | 134 | 26 | 158 |
| CCOP/NCORP | 1251 | 21 | 1096 | 86 | 1047 | 188 | 1144 |
| Non-SWOG | 1704 | 30 | 1565 | 123 | 1498 | 295 | 1796 |
| Total | 5030 | 90 | 4696 | 382 | 4651 | 850 | 5174 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 11 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 9 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 8 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 8 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 8 |
| OTHER | 10323 | Moonshot Biobank Research | 1 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 4 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 4 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 4 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 4 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 4 |
| LYMPH | AHOD2131 | cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy | 1 | 3 |
| GU | S1931 | RENAL, Stg IV, IO + Nephrectomy. vs IO Only | 1 | 3 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 3 |
| GI | S2303 | Gas/Esoph/GEJ, Adv, Ram + Pac +/- Nivo | 1 | 3 |